Omnicomm Systems Inc (OMCM) 0.2150 $OMCM OmniComm

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Omnicomm Systems Inc (OMCM) 0.2150 $OMCM

OmniComm Systems, Inc. Reports Financial Results for the Quarter Ended June 30, 2016
GlobeNewswire - Mon Aug 15, 7:00AM CDT
OmniComm Systems, Inc. ("OmniComm" (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced its financial results for the quarter ended June 30, 2016.

Medical Product Stock Earnings Coming Up: IMMY, OMCM, CLRB
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 6:50AM CDT
For the rest of the season, earnings are anticipated to grow 4.7%, driven by impressive top-line growth expectation of 7.7% in Medical sector.
CLRB: 2.34 (-0.01), IMMY: 3.91 (+0.09)

Global Top 15 Pharma Company Signs 3 Year Agreement for OmniComm Systems' TrialOne(R)
GlobeNewswire - Thu Aug 04, 7:02AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that a global top 15 pharmaceutical organization selected TrialOne to automate its entire Phase I and BA/ BE clinic. The expressed aims are to standardize processes, improve business intelligence, ensure compliance, and achieve overall business transformation within its early phase research.

OmniComm Systems Signs Multi-Million Dollar, Five Year Agreement with Top 5 US Medical Research University
GlobeNewswire - Tue Aug 02, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that one of the top 5 medical research universities in the US, selected OmniComm TrialMaster(R) EDC and related services to conduct a series of clinical studies over a five year period.

OmniComm Systems' Inaugural European Innovation Forum a Major Success
GlobeNewswire - Thu May 19, 7:00AM CDT
OmniComm Systems, Inc. ("OmniComm" (OTCQX:OMCM), a global leading provider of clinical data management technology, held its inaugural European customer summit. The two day event provided a forum for OmniComm customers to network, share current innovations, best practices and demonstrate the transformative impact of OmniComm's technology on clinical development and research. The Innovation Forum was held at the Centre of Human Drug Research, co-located with OmniComm Systems' office in Leiden, The Netherlands.

OmniComm Systems, Inc. Reports Financial Results for the Quarter Ended March 31, 2016
GlobeNewswire - Tue May 17, 7:00AM CDT
OmniComm Systems, Inc. ("OmniComm" (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced its financial results for the quarter ended March 31, 2016.

OmniComm Systems Signs Five-Year, Multi-Million Dollar TrialMaster EDC Agreement with CROMSOURCE
GlobeNewswire - Tue Apr 26, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced the signing of a five-year, multi-million dollar agreement with CROMSOURCE, a leading contract research organization (CRO), headquartered in Verona, Italy, with offices throughout Europe and North America. OmniComm's TrialMaster electronic data capture (EDC) suite will be used for the collection of clinical data during this five-year term in trials spanning all clinical phases and numerous therapeutic areas.

OmniComm Systems Penetrates Growing Israeli Life Sciences Market
GlobeNewswire - Mon Apr 11, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced the signing an agreement with Medistat Ltd., a leading data management and biostatistics organization, headquartered in Tel Aviv, Israel. OmniComm's TrialMaster electronic data capture (EDC) suite will be used to address the clinical trial needs of the growing Israeli life sciences sector which consists of more than 1300 organizations.

OmniComm Systems, Inc. Reports Financial Results for the Year Ended December 31, 2015
GlobeNewswire - Thu Mar 31, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today reported financial results for the year ended December 31, 2015.

OmniComm Systems(R) to Present EHR to EDC eSource Strategies at eClinical Forum Webinar
GlobeNewswire - Tue Feb 09, 7:15AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global provider of clinical data capture technology, announced that it will present at the eClinical Forum "Birds of a Feather" webinar on the topic of "eSource Strategies Between Electronic Health Records (EHR) and Electronic Data Capture (EDC)". The presentation will focus on industry drivers for EDC to EHR integration, and review feedback from a recent eSource market survey conducted by OmniComm. OmniComm will also provide a proof-of-concept demonstration on how data can be pulled from an EHR system into the TrialMaster(R) EDC technology.

OmniComm Systems' TrialMaster(R) EDC Technology Enables Global Biopharmaceutical Company to Streamline Clinical Development Time and Increase Product Success
Marketwired - Mon Dec 28, 7:00AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, today announced the expanded use and adoption of TrialMaster electronic data capture (EDC) by a leading global biopharmaceutical company across its entire pipeline of drug candidates. In 2015 this biopharmaceutical company used TrialMaster to run 23 clinical trials. Since selecting TrialMaster the company has run more than 65 clinical studies across 1,300 investigational sites recruiting more than 3,000 trial volunteers.

OmniComm Systems Achieves Major Milestone With Over 1,500 Active TrialOne Users Worldwide
Marketwire Canada - Wed Dec 16, 7:00AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announces major milestone achievements for TrialOne. TrialOne is used in a variety of clinics, supporting both healthy and patient driven early phase studies across a multitude of therapeutic areas and study types. Within one year TrialOne has been deployed in early phase clinics that account for over 1,100 beds, 1,500 users and over 470 clinical studies annually.

OmniComm Systems(R) Named as a Top 10 Clinical Data Management Solution Provider
Marketwired - Thu Dec 10, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, today announced its inclusion as one of the top 10 clinical data management solution providers in 2015 by Pharma Tech Outlook. Pharma Tech Outlook has chosen OmniComm Systems as one of the Top 10 Clinical Data Management Solution Providers of 2015. The positioning is based upon an evaluation of OmniComm's capabilities in providing the market with a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments.

Omnicell's (OMCL) Battles Escalating Costs: Should You Dump?
Zacks Equity Research - Zacks Investment Research - Mon Dec 07, 2:55PM CST
On Dec 7, 2015, we issued an updated research report on Omnicell, Inc. (OMCL).
MDRX: 13.03 (+0.30), OMCL: 38.03 (+0.57), ATHN: 122.89 (+0.80)

3 Reasons Value Stock Investors Will Love OmniComm Systems (OMCM)
Zacks Equity Research - Zacks Investment Research - Fri Dec 04, 7:43AM CST
OmniComm Systems (OMCM) is an impressive stock as it has a strong Value Score, favorable Zacks Rank and is also seeing positive estimate revisions.

OmniComm Systems Announces Results of eSource Survey: Industry Leaders See Increasing Role of Technology to Transform Clinical Development
Marketwired - Thu Dec 03, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announced the results of an industry wide survey to understand the challenges facing sponsors and contract research organizations (CROs) in their quest for efficient data collection. The majority of the respondents were from sponsors (biopharmaceutical organizations) and CROs, 42% and 32% respectively. At least half of respondents indicated that more than 50% of site source records are still maintained on paper.

The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
Zacks Equity Research - Zacks Investment Research - Wed Nov 25, 8:30AM CST
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
AIRM: 34.54 (+0.46), GILD: 78.17 (-1.60), MYL: 43.22 (+0.19)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 495

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 0

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 269

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 287

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 399

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 0

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing in Cryptocurrency Through Sustainable Mining Solutions

Updated Category News Views 132

Ripple and Dogecoin Capture Market Attention Recently, Ripple, known by its trading symbol XRP, regained significant visibility in the cryptocurrency market following a major legal victory against a regulatory body. This resurgence has reignited interest among investors and enthusiasts alike. Meanwhile, Dogecoin has been experiencing a renaissance, driven by the ambitious...

Continue Reading
General Dynamics Sees Growth in Q2 Earnings and Revenue

Updated Category News Views 147

General Dynamics Q2 Financial Highlights General Dynamics reported remarkable financial results for the second quarter of 2025, showcasing a revenue of $13 billion, which marks an 8.9% increase compared to the same quarter last year. The company achieved operating earnings of $1.3 billion, translating to a diluted earnings per share (EPS) of $3.74, reflecting a 14.7%...

Continue Reading
FIU Shines as a Top Public University in New Ranking

Updated Category News Views 77

FIU Ranks High in TIME's New College List Alright, listen up. The latest college buzz isn't just noise—Florida International University (FIU) is sitting pretty at No. 23 among public universities in TIME's first crack at America's Best Colleges for the 2026-2027 term. They're also punching in at No. 62 overall out of 500 schools. For a university that's been...

Continue Reading
Recent Net Asset Value Disclosure for Hargreave Hale AIM VCT

Updated Category News Views 174

Understanding the Latest Net Asset Value Announcement The Hargreave Hale AIM VCT PLC has recently made an important announcement regarding its Net Asset Value (NAV). This provides valuable insights for investors and stakeholders looking to evaluate the fund's performance. It is crucial for those following this investment vehicle to stay informed about NAV updates, as...

Continue Reading
Orvana Minerals Corp. Reports Financial Results for Q1 FY2026

Updated Category News Views 191

Orvana Minerals Corp. Financial Performance Overview TSX:ORV Orvana Minerals Corp. (TSX: ORV) has recently disclosed its financial statements for the first quarter of the fiscal year 2026 through its subsidiary, Empresa Minera Paitití, S.A. (EMIPA). These unaudited results are now available for viewing on the Bolivian stock market. The disclosure marks an important...

Continue Reading